
Medpace Holdings, Inc.
MEDPNASDAQHealthcare● Active
$457.14
+$2.89(+0.64%)
Market Cap$13.1B
P/E Ratio—
52W High$628.916
52W Low$293.2
Medpace Holdings, Inc. (MEDP) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MEDP · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.53B | $2.11B | $1.89B | $1.46B | $1.14B |
| Cost of Revenue | $1.77B | $1.45B | $1.36B | $1.03B | $0.81B |
| Gross Profit | $0.76B | $0.66B | $0.52B | $0.43B | $0.33B |
| Gross Margin %(computed) | 30.06% | 31.12% | 27.81% | 29.62% | 28.73% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.18B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.23B | $0.21B | $0.19B | $0.15B | $0.13B |
| Operating Income | $0.53B | $0.45B | $0.34B | $0.28B | $0.20B |
| Operating Margin %(computed) | 21.14% | 21.19% | 17.86% | 19.09% | 17.39% |
| Interest Income | $0.00B | $0.02B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.54B | $0.48B | $0.34B | $0.28B | $0.20B |
| Income Tax Expense | $0.09B | $0.07B | $0.05B | $0.04B | $0.02B |
| Net Income | $0.45B | $0.40B | $0.28B | $0.25B | $0.18B |
| Net Margin %(computed) | 17.83% | 19.17% | 15.00% | 16.81% | 15.92% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $15.64 | $13.06 | $9.20 | $7.57 | $5.06 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.04B |
| EBITDA | $0.57B | $0.48B | $0.36B | $0.30B | $0.22B |
| EBITDA Margin %(computed) | 22.55% | 22.58% | 19.26% | 20.62% | 19.23% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Medpace Holdings, Inc. data
About Medpace Holdings, Inc. (MEDP) Income Statement
Medpace Holdings, Inc. (MEDP) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MEDP reported revenue of $2.53B, gross profit of $0.76B (gross margin 30.06%), and net income of $0.45B — a net profit margin of 17.83%.
Frequently asked questions
MEDP · 4 questionsMedpace Holdings, Inc. (MEDP) reported revenue of $2.53B for 2025, up 20.0% year-over-year.
MEDP revenueMEDP salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08